Spinal fluid study aims to unlock secrets of rare muscle disease
NCT ID NCT06075693
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the spinal fluid and brain activity of people with myotonic dystrophy type 1, a condition that affects muscles and thinking. Researchers want to find early signs of disease in the fluid that surrounds the brain. About 88 adults will take part, including some without the disease for comparison. No treatment is given—the goal is to learn more and improve future diagnosis and care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOTONIC DYSTROPHY TYPE-1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02129, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists hunt for biomarkers to unlock DM1 treatments
- Could virtual reality help kids with a rare muscle disease read emotions better?
- No travel needed: new study uses video calls to uncover genetic secrets of childhood muscle disease
- Brain scans reveal diabetes link to cognitive decline in rare disease
- New study aims to uncover why people with muscle disease fall
- Heart risk study for muscular dystrophy patients completed